Capital World Investors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-360,217
Closed -$10.1M 539
2022
Q4
$10.1M Buy
360,217
+4,815
+1% +$123K ﹤0.01% 483
2022
Q3
$8.32M Sell
355,402
-5,904
-2% -$178K ﹤0.01% 495
2022
Q2
$12.2M Buy
361,306
+10,287
+3% +$360K ﹤0.01% 485
2022
Q1
$12.3M Sell
351,019
-147,179
-30% -$5.03M ﹤0.01% 515
2021
Q4
$15.2M Buy
498,198
+8,670
+2% +$282K ﹤0.01% 541
2021
Q3
$16.1M Buy
489,528
+102
+0% +$3.26K ﹤0.01% 537
2021
Q2
$14.8M Buy
+489,426
New +$16.1M ﹤0.01% 545

Other funds holding OGN

Capital World Investors's OGN Position: Q1 2023 in Review

Capital World Investors sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 360,217 shares — an estimated $10.1M sold.

Capital World Investors first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $16.1M in Q3 2021. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Capital World Investors reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Capital World Investors sold 360,217 Organon & Co shares in Q1 2023, an estimated $10.1M.
  • Capital World Investors first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • Capital World Investors's Organon & Co position peaked at $16.1M in Q3 2021.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Capital World Investors's 13F filing for Q1 2023, filed 15 May 2023.